World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Browse Articles or use Lyrarc's US patented "Groups" and "Links" for new insights. A Lyrarc Group of Articles on a topic gives insights into particular angles shown in the Group Title. A Lyrarc Link shows more specific insights for 2 articles.
All Topics Links
The risks to the Chinese economy of accumulated problems in the financial system
05/25/2011
A Wall Street Journal editorial that draws attention to the opaqueness of the financial system and its accummulated problems. It raises questions about how this will come out. Other expert observers have raised these questions.
Linked Articles
Wall Street Journal 05/25/2011
Beijing's Financial Day of Reckoning Is NearWall Street Journal 06/21/2011
Pfizer and Merck organize R&D using international innovation hubs- 2011-2015
05/02/2011
Efforts to tap into the latest external science at universities and research centers outside company labs is leading pharmaceutical companies to try a different approach to R&D. Pfizer closed its R&D facility in Sandwich, England and opened one in Cambridge. It opened hubs in Boston, La Jolla. Merck has followed this approach with a decision to setup innovaton hubs in Boston, San Francisco, London and Shanghai.
Linked Articles
Merck Plans Radical Overhaul of Drug R&D Unit
Wall Street Journal 12/28/2013
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
Research and Development (R&D) approaches of pharmaceutical companies Pfizer and Glaxo with smaller budgets and smaller units
07/01/2010
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Glaxo Tries Biotech Model to Spur Drug InnovationsWall Street Journal 07/01/2010
Why the Obama health care law gets an "F" grade from the Dean of Harvard Medical School
11/18/2009
The failure to replace the "fee-for-service" system in favor of capitated payments is cited as one of the main reasons. The other reasons are it does not resolve the issues of introducing competition in quality of care and cost, and continues the practices that disguise the true cost of care with a highly fragmented system of care. In a op-ed, Jeffrey Flier, Dean of the Harvard Medical School, gives a detailed account for the reason for his grading. A poorly drafted or incomplete law says Flier can make things worse, citing the example of the health care law in Massachusetts which is driving up costs, as it does not change the old dysfunctional system's key features such as "fee-for service," and instead tries to build a new system on broken foundations. Pearlstein in the Washington Post says the Obama health care law has addressed the "fee-for-service" problem, but this is really not the case, and Flier's reasoning may be the clue to the deeper problem for the Obama health care law.
Linked Articles
Steven Pearlstein: Eat your broccoli, Justice Scalia - The Washington Post
Washington Post 04/01/2012
Health 'Debate' Deserves a Failing GradeWall Street Journal 11/18/2009
The different approaches of Pfizer and Novartis for new drug research and development in 2009-2015
06/11/2009
Working with smaller R&D budgets and focussing the research on a few areas, collaboration with universities, and other ways to get more out of the R&D dollar.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Novartis: Radically Remaking Its Drug BusinessBusinessWeek 06/11/2009
Roche's integration of Genentech into its operations.
07/24/2008
During the early stages of the acquisition of Genentech questions were raised whether the bigger Swiss compay would end up stifling the research culture at Gennetech and reaearch scientists woul leave. As it turned out few have left and Roche head Severin Schwan has committed Roche to focussing on research as ahuge opportunity for pharmaceuticals as he sees drugmaking still "so crude," and the opportunities vast with advances in biotechnology, diagnostics, and genomics.
Linked Articles
Economist 12/10/2009
Roche's Big Hurdle with GenentechBusinessWeek 07/24/2008
Pfizer's focus on its core pharmaceutical business in 2011-2015
05/02/2011
Rockoff's interview with Pfizer CEO, Ian Read, in which Read describes his strategy of focussing on new drug development and locating closer to hubs with large universities and research centers such as La Jolla, Cambridge, Massachusetts, and Cambridge, England. Pfizer sold its infant nutrition business to Nestle as part of this plan.
Linked Articles
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Life Beyond Lipitor for Pfizer ChiefWall Street Journal 05/02/2011
Bill Gates calls for targeted investment in education
02/28/2011
The Bill and Melinda Gates Foundation will invest $290 million in a program to be launched at selected school districts. The programs are designed around improving teacher effectiveness and new personnel systems.
Linked Articles
Bill Gates Seeks Formula for Better Teachers
Wall Street Journal 03/22/2011
Bill Gates - How teacher development could revolutionize our schoolsWashington Post 02/28/2011
Shiller, Charles Scwab and other experts on the nervousness of the individual investor.
05/14/2010
Charles Schwab says about 98% of individual investos are nervous in mid 2010. He questios whether safety an soundess mean anything anymore. Shillers Buy on Dips Index confirms Schwab's observations.
Linked Articles
Chuck Schwab Is Worried About Small Investors. Should We Worry Too?
BusinessWeek 05/27/2010
Fear of a Double Dip Could Cause OneNew York Times 05/14/2010
U.S. president Obama, lobbyists and the 2010 Obama health care law
07/24/2009
The political process and the influence of lobbyists on Congress and the White House constrains the development of laws that control healthcare costs. Higher health care costs means less money for infrastructure development, education, research and development funding, and other priorities which build a future for Americans.
Linked Articles
E-Mails Highlight Extent of Obama's Deal With Industry on Health Care
New York Times 06/08/2012
Obama's Health Expert Gets PoliticalWall Street Journal 07/24/2009
Warnings on energy by Stewart Udall, interior secretary under John Kennedy.
11/16/2008
Innovative public transportations systems that the automakers could do research and development to develop.
Linked Articles
Have You Driven a Bus or a Train Lately?
New York Times 11/16/2008
How High Gas Prices Can Save the Car IndustryNew York Times 11/16/2008
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us